527.00 -1.58 (-0.30%)
After hours: 7:40PM EDT
|Bid||524.01 x 1000|
|Ask||535.99 x 1400|
|Day's range||526.68 - 535.40|
|52-week range||244.98 - 573.99|
|Beta (5Y monthly)||0.86|
|PE ratio (TTM)||78.77|
|Earnings date||04 May 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||565.83|
IDEXX Laboratories, Inc. (NASDAQ: IDXX) stock has been a coronavirus winner, climbing over 90% since January 2020 and soundly beating the S&P500. On a Motley Fool Live episode recorded on March 17, Fool contributors Brian Feroldi and Brian Withers discuss its latest quarter and what could drive sustained growth in the future. Brian Feroldi: We're talking about IDEXX labs, ticker symbol I-D-E-X-X. IDEXX has three primary businesses, although two of them are almost irrelevant because the one business but we really like.
Logitech, Harley-Davidson, Fulgent Genetics, Bio-Rad Laboratories and IDEXX Laboratories highlighted as Zacks Bull and Bear of the Day
Today, let's look at three companies in this sector, Elanco (NYSE: ELAN), Trupanion (NASDAQ: TRUP), and IDEXX Laboratories (NASDAQ: IDXX), and how they can add both bark and bite to your portfolio. Elanco is a pharmaceutical company that develops medications and vaccines for pets and livestock.